In bladder cancer cells treated with nimbolide, the G2/M phase cell cycle was arrested via the checkpoint kinase 2 (Chk2)/Cdc25C and Chk2/p21WAF1-related cyclin B1/Wee1 pathway. The gene discussed is CDC25C; the disease is urinary bladder cancer.